Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)

Name: Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)
License: Public Domain

SWOG Cancer Research Network

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

bladder carcinoma infiltrating the muscle of the bladder wall, infiltrating renal pelvis and ureter urothelial carcinoma, stage ii bladder cancer ajcc v8

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 390927
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.